The aim of this course is to give students insight into current developments in pharmaceutical policy making as well as to give them a better understanding of the methods available for analysing the effects of policy interventions.
Medicines are among the most regulated products in society. From the earliest pre-clinical stages onward, policy makers want to foster the development of safe, effective and affordable medicines for patients in need of pharmacotherapy. When a drug reaches the market, it is the beginning of a process of complex interactions between patients, prescribers, insurers, pharmaceutical companies and governments. Furthermore, the inequity in access to medicines is still a defining characteristic of the global pharmaceutical market place. The aim of the course is to give students insight into current developments in pharmaceutical policy making as well as to give them a better understanding of the methods available for analysing the effects of policy interventions.
You will experience an intensive programme covering the following topics: pharmaceutical policy analysis issues and methods; availability and affordability of medicines; universal health coverage; pricing and reimbursement (including the role of health technology assessment); regulatory issues and challenges; policy and politics; synthesis, case studies & public health.
Prof. Dr. Marieke de Bruin, Prof. Dr. Aukje Mantel-Teeuwisse, Prof. Dr. Wim Goettsch, Dr. Rianne van den Ham and others.
(Post)graduates and professionals within governments, NGOs, industry, universities with a basic knowledge of public health/medicine, who have an interest in the policy aspects of pharmaceuticals and/or pharmacoepidemiology.
The aim of the course is to give students insight into current developments in pharmaceutical policy making as well as to give a better understanding of the methods available for analysing the effects of policy interventions.
One week, full-time
Participants that are affiliated to an institution based in a low- and middle-income country (as classified by the World Bank) can apply for a 50% reduction on the course fee. Please email the course director to discuss this.
The course can be combined with the course M08 Pharmacoepidemiology and Drug Safety running from 8 - 12 July 2024. The combination fee is €1800,- when you participate in both courses. This discount will only be visible after acceptance to the course.
The housing costs do not include a Utrecht Summer School sleeping bag. This is a separate product on the invoice. If you wish to bring your own bedding, please deselect or remove the sleeping bag from your order.
For this course you are required to upload the following documents when applying: